Kг©pernyе‘kг©p 2022-12-27 221341.jpg -

: Create inhibitors that the viral proofreader cannot detect or remove , effectively sabotaging the virus's ability to replicate within a host cell.

One of the most fascinating aspects of SARS-CoV-2 is its ability to correct errors during replication, a rare trait for RNA viruses.

: Prevent the virus from making full-length copies of its genome. KГ©pernyЕ‘kГ©p 2022-12-27 221341.jpg

This intricate chemical battle at the microscopic level remains a primary focus for developing novel antiviral drugs that can withstand the virus's natural evolutionary defenses.

By understanding this "molecular handshake" between the copier and the proofreader, researchers aim to design drugs that: : Create inhibitors that the viral proofreader cannot

: To prevent errors, it employs a "proofreading" complex (nsp10–nsp14). Research found that this complex is highly specific—it looks for the presence of certain chemical groups (2′OH and 3′OH) on the RNA backbone to identify where it needs to work.

: Scientists discovered that certain analogues, like Cordycepin, can "trick" the virus. The RdRp incorporates these fake building blocks, causing the "photocopier" to jam and the "proofreader" to fail because it doesn't recognize the modified chemical structure. Therapeutic Potential This intricate chemical battle at the microscopic level

: The virus uses a complex called the RNA-dependent RNA polymerase (RdRp) , which acts like a biological photocopier.